PD-L1 Proteins
(CD274 (PD-L1))
Involved in the costimulatory signal essential for T- cell proliferation and IFNG production in a PDCD1-independent manner. Interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production.
Recommended next Filters:
Would you like to try our new AI Search?
80 results
PD-L1
Origin: Mouse
Host: Mammalian Cells
Recombinant
>90 % as determined by SDS-PAGE.
WB, SDS, ELISA, Imm, AcA
Active
1 image
PD-L1
Origin: Human
Host: Wheat germ
Recombinant
WB, ELISA, AP, AA
1 image
PD-L1
Origin: Mouse
Host: HEK-293 Cells
Recombinant
> 98 % as determined by SDS-PAGE
Active
1 image
PD-L1
Origin: Human
Host: Escherichia coli (E. coli)
Recombinant
> 90% by SDS-PAGE
SDS
1 image
PD-L1
Origin: Human
Host: Baculovirus infected Insect Cells
Recombinant
> 95% by SDS-PAGE
SDS, AcA
Active
1 image
PD-L1
Origin: Mouse
Host: HEK-293 Cells
Recombinant
>95 % as determined by SDS-PAGE.
Active
PD-L1
Origin: Human
Host: HEK-293 Cells
Recombinant
>95 % as determined by SDS-PAGE.
Active
PD-L1
Origin: Cynomolgus, Rhesus Monkey
Host: HEK-293 Cells
Recombinant
>95 % as determined by SDS-PAGE.
Active
PD-L1
Origin: Mouse
Host: HEK-293 Cells
Recombinant
>95 % as determined by SDS-PAGE.
Active
PD-L1
Origin: Human
Host: HEK-293 Cells
Recombinant
>95 % as determined by SDS-PAGE.
Active
PD-L1
Origin: Human
Host: HEK-293 Cells
Recombinant
The purity of the protein is greater than 95 % as determined by SDS-PAGE and Coomassie blue staining.
PD-L1
Origin: Human
Host: HEK-293 Cells
Recombinant
The purity of the protein is greater than 95 % as determined by SDS-PAGE and Coomassie blue staining.
PD-L1
Origin: Human
Host: Escherichia coli (E. coli)
Recombinant
> 95 % as determined by reducing SDS-PAGE.
PD-L1
Origin: Dog
Host: HEK-293 Cells
Recombinant
The purity of the protein is greater than 95 % as determined by SDS-PAGE and Coomassie blue staining.
PD-L1
Origin: Human
Host: Human Cells
Recombinant
> 95 % as determined by reducing SDS-PAGE.
PD-L1
Origin: Human
Host: Human Cells
Recombinant
> 95 % as determined by reducing SDS-PAGE.
PD-L1
Origin: Mouse
Host: Human Cells
Recombinant
> 95 % as determined by reducing SDS-PAGE.
PD-L1
Origin: Human
Host: Human Cells
Recombinant
> 95 % as determined by reducing SDS-PAGE.
PD-L1
Origin: Mouse
Host: Human Cells
Recombinant
> 95 % as determined by reducing SDS-PAGE.
PD-L1
Origin: Rat
Host: Mammalian Cells
Recombinant
Greater than 95 % as determined by SDS-PAGE.
WB, ELISA
Latest Publications for our PD-L1 Proteins
: "Focused Ultrasound-Enhanced Delivery of Intranasally Administered Anti-Programmed Cell Death-Ligand 1 Antibody to an Intracranial Murine Glioma Model." in: Pharmaceutics, Vol. 13, Issue 2, (2021) (PubMed).: "PD-L1 aptamer isolation via Modular-SELEX and its applications in cancer cell detection and tumor tissue section imaging." in: The Analyst, Vol. 146, Issue 9, pp. 2910-2918, (2021) (PubMed).
: "Blocking interaction between SHP2 and PD-1 denotes a novel opportunity for developing PD-1 inhibitors." in: EMBO molecular medicine, Vol. 12, Issue 6, pp. e11571, (2020) (PubMed).
: "Prophylactic In Vivo Hematopoietic Stem Cell Gene Therapy with an Immune Checkpoint Inhibitor Reverses Tumor Growth in Syngeneic Mouse Tumor Models." in: Cancer research, Vol. 80, Issue 3, pp. 549-560, (2020) (PubMed).
: "Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer. ..." in: Nature medicine, Vol. 26, Issue 5, pp. 732-740, (2020) (PubMed).
: "Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity." in: Cancer immunology, immunotherapy : CII, (2020) (PubMed).
: "In Vitro Assays to Study PD-1 Biology in Human T Cells." in: Current protocols in immunology, Vol. 130, Issue 1, pp. e103, (2020) (PubMed).
: "Comprehensive in vitro characterization of PD-L1 small molecule inhibitors. ..." in: Scientific reports, Vol. 9, Issue 1, pp. 12392, (2019) (PubMed).
: "Enhanced Expression of PD-L1 on Microglia After Surgical Brain Injury Exerts Self-Protection from Inflammation and Promotes Neurological Repair." in: Neurochemical research, Vol. 44, Issue 11, pp. 2470-2481, (2019) (PubMed).
: "A small-sized protein binder specific for human PD-1 effectively suppresses the tumour growth in tumour mouse model." in: Journal of drug targeting, pp. 1-9, (2019) (PubMed).
Aliases for PD-L1 Proteins
CD274 molecule (CD274) ProteinsCD274 antigen (Cd274) Proteins
programmed cell death 1 ligand 2 (PDCD1LG2) Proteins
CD274 molecule (Cd274) Proteins
A530045L16Rik Proteins
B7-H Proteins
B7H1 Proteins
B7h1 Proteins
PD-L1 Proteins
PDCD1L1 Proteins
Pdcd1l1 Proteins
PDCD1LG1 Proteins
Pdcd1lg1 Proteins
PDL1 Proteins
Pdl1 Proteins
RGD1566211 Proteins
Did you look for something else?
- PD-1 Proteins
- PCYT2 Proteins
- PCYOX1L Proteins
- PCYOX1 Proteins
- PCTP Proteins
- PCSK7 Proteins
- PCSK5 Proteins
- PCSK4 Proteins
- PCSK2 Proteins
- PCSK1N Proteins
- PCSK1 Proteins
- PCP4 Proteins
- Pcp2 Proteins
- PCOLCE2 Proteins
- PCOLCE Proteins
- PCNP Proteins
- PCNA Proteins
- PCMTD1 Proteins
- PCMT1 Proteins
- PCM1 Proteins
- PDAP1 Proteins
- PDCD1LG2 Proteins
- PDCD2 Proteins
- PDCD2L Proteins
- PDCD5 Proteins
- PDCD6 Proteins
- PDCD7 Proteins
- PDCL2 Proteins
- PDCL3 Proteins
- PDE10A Proteins
- PDE11A Proteins
- PDE12 Proteins
- PDE1A Proteins
- PDE1B Proteins
- PDE1C Proteins
- PDE2A Proteins
- PDE3A Proteins
- PDE4A Proteins
- PDE4B Proteins
- PDE4C Proteins
You are here:
